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ABSTRACT: Conformation and dynamics of the vasoconstrictive peptides human urotensin-
II (UII) and urotensin related peptide (URP) have been investigated by both unrestrained and 
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enhanced-sampling molecular-dynamics (MD) simulations and NMR spectroscopy. These 
peptides are natural ligands of the G-protein coupled urotensin II receptor (UTR) and have 
been linked to mammalian pathophysiology. UII and URP cannot be characterized by a single 
structure but exist as an equilibrium of two main classes of ring-conformations, open and 
folded, with rapidly interchanging subtypes . The open states are characterized by turns of 
various types centered at K8Y9 or F6W7 predominantly with no or only sparsely populated 
transannular hydrogen bonds. The folded conformations show multiple turns stabilized by 
highly populated transannular hydrogen bonds comprising centers F6W7K8 or W7K8Y9. Some 
of these conformations have not been characterized previously. The equilibrium populations 
that are experimentally difficult to access were estimated by replica-exchange MD 
simulations and validated by comparison of experimental NMR data with chemical shifts 
calculated with density-functional theory. UII exhibits approximately 72% open : 28% folded 
conformations in aqueous solution. URP shows very similar ring conformations as UII but 
differs in an open:folded equilibrium shifted further towards open conformations (86:14) 
possibly arising from the absence of folded N-terminal tail - ring interaction. The results 
suggest that the different biological effects of UII and URP are not caused by differences in 
ring-conformations but rather by different interactions with UTR. 
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INTRODUCTION 
The neuropeptide urotensin-II (UII) was originally found in the urophysis of teleost fishes.1 
A human homolog2 of the orphan receptor GPR143 (a G-protein coupled receptor (GPCR) 
that is very similar to the somatostatin receptor first isolated from rats) was identified in 
1999.4-6 UII is the natural ligand of this receptor, now called the urotensin II receptor 
(UTS2R, UTR). All vertebrate isoforms of UII show a highly conserved C-terminal sequence: 
a cyclic 6-residue moiety (CFWKYC) closed by a disulfide bridge and flanked by valine as 
extra-annular residue (Scheme 1).7 The length of the N-terminus of human UII is four 
residues but this is species variable, so that the total peptide length ranges from 11 residues 
for human UII up to 17 for hamster UII.7-10 Urotensin related peptide (URP) is a paralog of 
UII.11 It has the same C-terminal cyclic moiety as UII but the extra-annular N-terminus of UII 
is replaced by a single alanine at position 1 in URP (Scheme 1).12 The 6-membered ring 
closed by a disulfide-bridge is a common motif with other hormone peptides, such as Arg8-
vasopressin and Leu8-oxytocin. UII is the most potent vasoconstrictive natural peptide 
known2 and both UII and URP are thought to be involved in important physiological 
processes such as cardiovascular regulation, endocrine and behavioral effects.7, 8, 11, 13 
a b 
Scheme 1. a) Human Urotensin-II (UII) and b) Urotensin Related Peptide (URP) 
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Consequently, they are linked to a multitude of pathophysiological processes such as 
atherosclerosis, heart failure, and many more.7, 8, 11, 13, 14 
  
Although UII and URP show similar potency at the UTR12, 15, 16 and apparently have 
overlapping binding sites,17 their signaling outcomes may, nevertheless, differ.13 UII can 
behave as an almost irreversible UTR agonist, and the two peptides can affect astrocyte 
activity differently.18, 19 The effects of UII or URP are often not conserved across species11, 20 
and may even be opposite (vasoconstrictive and vasodilative) within the same species.21 In 
summary, the urotensinergic system is far from being well understood. Multiallosteric 
interactions of receptor and ligands or biased agonism that ultimately trigger different 
functions have been hypothesized.22  
Biological activity studies have shown that the ring sequence UII(4-11)
 is necessary to retain 
full agonistic potency16, 23 and that the motif is essential for receptor activation.23, 24 An intact 
bridge also seems essential,16, 25, 26 but need not be a disulfide.25 However, recently, the first 
acyclic peptide agonist for UTR has been described, a UII-analog that still suggests WKY to 
be the receptor-activating motif.27 Nuclear magnetic resonance (NMR) studies in water24, 28 
and dimethyl sulfoxide,29 supported by circular dichroism (CD) spectroscopy,28 have been 
interpreted to indicate an unstructured form for human UII with no classical turns or 
intramolecular hydrogen bonds. However, Lescot et al.30 inferred, from NMR studies, a 
widened 7,8,9 γ-turn and a 8,9,10 γ-turn with close W7O-Y9HN and K8O-C10HN distances for 
the human UII conformation in water, thus localizing a turn center in the ring at residues K8 
and Y9. All NMR investigations show the N-terminal tail to be more flexible than the ring. 
URP has been suggested from the NMR experiments by Chatenet et al.15 to have an inverse 
4,5,6 γ-turn centered at K5 in water with the intramolecular hydrogen bond W4O-Y6HN. NMR 
experiments by Brancacchio et al.31, however, suggest structural flexibility in aqueous 
solution and a high similarity of URP and UII ring-conformations. Carotenuto et al.28 made 
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NMR studies of UII and the smaller URP-like version, UII(4-11), in sodium dodecyl sulfate 
(SDS) micelles mimicking a cell-surface environment. They found two slowly exchanging 
states: one specified as β-hairpin with a β-turn type II’ centered at W7 and K8, and another 
weakly populated, apparently, with a more flexible and random structure. The highly 
structured state was suggested to be the active conformation in the receptor-binding pocket. 
Analogous experiments for URP in SDS micelles suggested a very similar structure.31 
We now report unrestrained molecular dynamics (MD) simulations of human UII and URP 
with the Amber ff99sb force field on extended time-scales (see Table S1 and Figures S1-S6 of 
the Supporting Information, SI). These simulations are designed to investigate the 
conformational space of the peptides as completely as possible. To rule out small force-field 
artefacts that might become important for such small peptides, we have also performed 
additional unrestrained microsecond-scale MD simulations with the CHARMM c36b2 force 
field. These simulations revealed no significant difference between the conformations 
obtained with the two force fields, so that we concentrate on the AMBER results, which are 
more extensive.  Replica-exchange molecular dynamics (REMD) simulations have been used 
to improve the conformational sampling and to obtain thermodynamic information. The 
results are compared with NMR-spectroscopic experiments and a statistical model of the 
conformational equilibrium in aqueous solution is given. 
 
METHODS 
Molecular dynamics simulations. MD simulations of the peptides UII and URP were 
performed with Amber 10,32, 33 Amber 14 CUDA,34-37 and CHARMM c36b2.38 Amber 
calculations used the ff99SB force field.39 Comparison simulations with CHARMM 
parameter set 3638 were used to rule out force-field artefacts. REMD simulations were 
performed with Amber. All simulations were carried out with unrestrained distances and 
explicit water solvation. Further simulation details are given in the SI (pp S2-S7). 
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Conformational analysis. Conformational clustering of the backbone dihedrals (overall 
states) was performed with DASH.40, 41 Additional sub-clustering of the ring and tail 
conformations led to a classification of UII and URP conformations in terms of distinct ring-
state types. As representatives, the overall conformations of highest similarity to each ring-
state type were chosen, equivalent to cluster centers (Table S2). Hydrogen-bond populations 
and secondary structure motifs of characteristic conformations were calculated from 
corresponding sections of the MD trajectories using AmberTools with default settings.33, 34, 42 
Consistency of type assignments of states from different simulations was ensured by 
comparing the circular similarities of ring torsions, turn propensities and Cα alignments. 
Further details are given in the SI (p S8). 
Principal component analysis. A possible correlation of ring and tail motions was 
analyzed with principal component analysis (PCA) implemented in DASH.41 Torsion weights 
were calculated from the coefficients of the relevant principal components (PCs). The number 
of significant PCs was determined by Kaiser´s eigenvalue-one test.43 PC clustering was 
visualized via 3D-scatter plots of the three most significant principal components color-coded 
according to the assigned DASH states in SAR-caddle.44 Further details are given in the SI (p 
S2-S13). 
NMR. NMR spectra were recorded for human U-II and URP at pH 3.0/3.5 and pH 6.0 in 
H2O and D2O on a Varian Inova 600 MHz spectrometer. Proton resonance assignments were 
achieved using 2D 1H–1H total chemical shift correlation spectroscopy (TOCSY),45 and 1H-1H 
nuclear Overhauser effect spectroscopy (NOESY) NMR spectra.46 Resonance assignments of 
carbon and nitrogen at natural abundance were achieved through standard 13C-1H gradient 
heteronuclear single quantum coherence (gHSQC) and 15N-1H gHSQC experiments.47-49 
Details of sample preparation and NMR experiments are given in the SI (pp S14-S18). 
Density-functional theory (DFT) calculations on representative conformations. The 
geometries of representative conformations for UII and URP derived from the DASH analysis 
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were first optimized at the B3LYP50-53/6-31G(d)54-58 level with Gaussian 09, Revision C.01.59 
Water solvation was simulated with the default Polarizable Continuum Model (PCM) using 
the integral equation formalism variant (IEFPCM)).60 The DFT-optimized structures were 
then used to calculate the magnetic shielding tensors in solution at the same level of theory 
and converted to 1H, 13C, and 15N chemical shifts using regression formulae based on standard 
sets of chemical shifts and calculated values. The regression formulae and calculated chemical 
shifts are given in the SI (pp S19-S23, Figure S7, Tables S9-S11). 
Equilibrium models and experimental evaluation. Free energies and relative populations 
(equilibrium models) for the representative conformations of UII and URP were calculated 
from extended REMD simulations. For each peptide, three simulations of 500 ns were 
performed starting from different initial conformations (UII: omega-Iopen, folded-I, lasso; 
URP: omega-Iopen, omega-II, lasso). 
1H chemical shifts for the equilibria were calculated via 
linear combination of the calculated shifts for the representative conformations according to 
the populations suggested by REMD. The calculated shifts of representatives and 
conformational equilibria were then compared by linear regression with our experimental data 
for non-exchangeable 1H chemical shifts of UII and URP in aqueous solution at pH 6.0 and 
pH 3.5, respectively.  
We have recently published details of chemical-shift comparisons for the closely related 
vasopressin and have suggested statistical metrics for judging whether conformational 
equilibria suggested by simulations are consistent with experiment.61 Here, we used REMD to 
determine equilibrium populations, rather than the metadynamics. This substitution is tested 
here. 
Further details are given in the SI (pp S24-S28, Figures S8-S9, Table S13-S15). 
 
RESULTS AND DISCUSSION 
Conformations of Urotensin-II. 
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In total 35 µs of unrestrained MD simulations with the Amber ff99SB force field 
supplemented with 1.3 µs CHARMM c36b2 trajectories were used to explore the 
conformational space of UII (Tables S1 and S2 of the SI). The conformational analysis led to 
the classification summarized in Table 1. UII exhibits two main types of ring-states, unfolded 
open and saddle-like folded ring conformations, which are subdivided into a total of 11 
subtypes, each defined by its main turn center. Secondary structure propensities and 
populations of transannular hydrogen bonds are given in Table 2 and 3. 
Open ring-state types. Turns in this class are centered at residues K8Y9 or F6W7 (Table 3) 
with turns fluctuating around ideal β-turn angles (Table S3 of the SI). The majority of these 
turns have no or only sparsely populated transannular Oi-Hi+3 hydrogen bonds (Table 2). Only 
type scoop (6,7 β-I) and omega-Ihbond (8,9 β-I) exhibit significant transannular hydrogen-bond 
populations but the latter frequently interconverts with the open omega-Iopen state (8,9 β-VIII) 
resulting in an average population of 44.3% equivalent to an open turn. Additionally, a ring 
state was found with no defined β-turns in the ring (circle), a loop structure closed by 
hydrogen bond W7O-C5HN. The interpreted structures based on NMR studies of UII in 
aqueous solution resemble the open ring-state types (e.g. turn centers at residues 8,922 or no 
transannular hydrogen bonds20). Furthermore, the open omega conformations of UII show 
significant similarities to the clinched open states of the related peptide Arg8-vasopressin 
(AVP)62 (Table 4). The clinched open conformation of AVP, however, is only populated 
approximately 30% in aqueous solution.61 
Folded ring-state types. The second main cluster comprises saddle-like ring conformations 
with multiple turns, centered either at residues F6W7K8 or W7K8Y9 (Tables 1 and 3). This 
class shows highly populated transannular hydrogen-bonds that stabilize the folded 
conformations of the ring (Table 2). Subtype folded-I (turns centered at W7K8Y9 comprising a 
7,8 β-I turn) corresponds to the saddle state of AVP; subtype folded-IVb2 (a peptide-bond 
rotamer of folded-I with a 7,8 β-II turn) is equivalent to the twisted-saddle state of AVP. 
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Interestingly, for AVP, the folded saddle conformation is the most highly populated in 
aqueous solution,61, 63 whereas for UII, a folded conformation (β-hairpin centered at W7K8) 
has only been identified experimentally in SDS micelles.28 The SDS-conformation resembles 
the folded conformations found in our MD simulations. 
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Table 1. Classification of Ring Conformations of UIIa 
Open 
Ring-state type Turn type H-bond Subtype Cartoon IDb 
Turns centered at KY (8,9) 
 
8,9 β-I 7O-10H omega-Ihbond 
 
2 
8,9 β-VIII open omega-Iopen 1 
8,9 β-II open omega-II 3 
Turns centered at FW (6,7) 
 
6,7 β-I 5O-8H scoop 
 
5 
6,7 β-I 
+ 4,5 β-I (N-term) 
open lasso 4 
Loop without defined turn centers 
 
(5-9 loop) 9O-4H,5H circle 
 
10 
Folded (saddle-like) 
Ring-state type Turn type H-bond Subtype Cartoon IDb 
Multiple turns centered at FWK (6,7,8) or WKY (7,8,9) 
 
 
7,8,9 (7,8 β-I) 6O-(9H,10H) folded-I 
 
6 
7,8,9 (7,8 β-II) 6O-9H folded-IVb2 7 
 
 
6,7,8 
(5-9 310-helix) 
+ 4,5 β-I (N-term) 
6O-9H, 
5O-(8H,10H) 
3O-6H 
inv-folded 
 
11 
 
7,8,9 
(6-10 parallel sheet) 
+ 4,5 β-I (N-term) 
5O-(8H,9H,10H) 
3O-6H 
folded-II 
 
8 
6,7,8 
(6,7 β-III’) 
+ 4,5 β-I (N-term) 
5O-(8H, 9H) 
3O-6H 
folded-III 9 
a Ring-state types are characterized by their turn centers (blue) and the donor oxygen for transannular hydrogen-
bond interactions (red). Sidechains are indicated by the 1-letter code of the residue. Turn types and corresponding 
hydrogen bonds populated > 70% are listed.  
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b Mean torsion angles (Table S3) and coordinate files of representatives are given in the SI (ID = ID of 
representative)
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Table 2. Hydrogen-Bond Populationsa and Corresponding Turn Centers of UII Ring-State Types  
Hydrogen 
bonds 
Conformation (ring-state type) Turn 
center 
Open 
  Ω-Ihbond Ω -Iopen Ω-Iav
b Ω -II lasso scoop circle  
W7O C10H 88.1 18.8 44.3 6.0 0.0 0.0 0.0 8,9 
C5O K8H 0.0 0.0 0.0 0.0 12.4 73.8 0.0 6,7 
W7O Y9H 9.8 8.5 9.9 0.0 0.7 70.4 0.0 8 
Y9O C5H 0.0 0.0 0.0 0.0 0.0 0.0 96.3 (9-5 loop) 
Y9O D4H 0.0 0.0 0.0 0.0 0.0 0.0 92.4 (9-4 loop) 
Folded 
  folded-I folded-IVb2 inv-folded folded-II folded-III  
F6O Y9H 95.8 73.9 95.8 0.0 0.1 7,8 
F6O C10H 63.6 10.5 0.0 0.0 0.1 7,8,9 
C5O K8H 0.0 2.4 96.1 77.2 83.7 6,7 
C5O Y9H 0.0 0.1 0.2 99.4 98.2 6,7,8 
C5O C10H 0.0 0.0 96.9 89.3 0.3 (5-10) 
P3O F6H 0.9 0.2 68.0 84.3 85.1 4,5 
T2O W7H 0.0 0.0 0.0 0.0 61.6 (2-7) 
a Hydrogen-bond populations are relative to the lifetime of the ring state type; only those hydrogen bonds are listed 
that were found to be populated >50% for at least one ring state subtype; hydrogen bonds > 70% (presumably 
involved in classical turns) are shown in bold.  
b Average hydrogen-bond population for the frequently interconverting sub-types Ω-Ihbond and Ω-Iopen (cf. Figure 
S1 of the SI); Ω = omega. 
 
Table 3. Secondary Structure Populations (%) for Ring-State Types of UII 
UII 
Ring-state type Residue
a 
Motif
b
 
 T
2
 P
3
 D
4
 C
5
 F
6
 W
7
 K
8
 Y
9
 C
10
  
Open 
omega-Iopen 0.00 1.21 1.24 0.66 0.62 0.12 27.12 27.16 1.23 T 
omega-Ihbond 0.00 24.14 24.15 0.02 0.00 0.00 77.96 78.51 25.05 T 
omega-Iaverage 0.10 4.46 4.52 0.17 0.02 0.00 47.41 47.71 15.95 T 
omega-II 0.35 2.22 1.88 0.02 0.02 0.00 48.69 48.70 0.52 T 
scoop 0.00 3.04 3.04 0.00 86.91 86.94 0.15 7.79 7.79 T 
lasso 0.00 0.05 53.99 56.26 21.61 18.36 1.92 1.49 0.00 T 
circle 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 T 
Folded 
folded-I 1.02 10.04 11.83 2.50 0.09 75.10 75.22 67.70 3.20 T 
folded-IVb2 0.00 4.96 5.22 0.29 0.51 78.78 86.33 68.73 9.36 T 
inv-folded
 0.00 2.14 59.19 59.19 5.83 6.84 7.84 99.97 89.60 T 
 0.00 0.54 20.44 23.31 92.64 93.16 92.15 0.00 0.00 H 
folded-II 0.00 0.00 95.07 95.07 42.71 100.00 100.00 98.87 0.00 T 
 
0.00 0.00 0.00 0.00 57.29 0.00 0.00 0.00 56.47 P 
folded-III 24.93 43.33 63.97 64.83 99.90 99.65 99.69 13.04 0.44 T 
a Populations > 75% (classical turns) and > 25% (potentially open turn) are shown in bold and italics, respectively 
(for notation of secondary structure elements, see SI). 
b T = turn, P = parallel sheet, H = 310-helix 
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Table 4. Similarity of the Ring Torsions of UII(5-10), URP(2-8), and AVP(1-6)
a 
Conformation (ring-state type)b Circular similarityc Turn type 
UII URP AVP UII/URP UII/AVP UII URP AVP 
 Open 
1 omega-Iopen 3r omega-Iopen 12 cl.open 0.95 0.88 8,9 β-VIII 5,6 β-VIII 4,5 β-VIIIdist/I 
2 omega-Ihbond 1r omega-Ihbond 12 cl.open 0.99 0.83 8,9 β-I 5,6 β-I 4,5 β-VIIIdist/I 
3 omega-II 2r omega-II  - 0.93 - 8,9 β-II 5,6 β-II 4,5 β-II 
4 lasso 6r (lasso45pbr)
 
27 open 0.55d 0.55e 6,7 β-I 3,4 β-VIIIdist 2,3 
5 scoop - -  - - - 6,7 β-I - - 
10 circle - -  - - - (5-9 loop) - - 
 Folded 
6 folded-I - - 3 saddle - 0.93 7,8,9 (7,8 β-I) - 3,4,5 (β-I) 
7 folded-IVb2 4r hybrid 19 tw.saddle 0.89 0.95 7,8,9 (7,8 β-II) 4,5,6 γ 3,4,5 (β-II) 
  5r sheet  - 0.67 - - 4,5 (ap.sheet β-II) - 
11 inv-folded - -  - - - 6,7,8 (310-helix) - - 
8 folded-II - -  - - - 7,8,9 (p.sheet) - - 
9 folded-III - -  - - - 6,7,8 (6,7 β-III’) - - 
a () ring residues. 
b coordinate files of UII representative (UII 1 to 11, URP 1r to 6r) are given in the SI; coordinate files of AVP 
representatives (T16_3,12,19,27) have been published previously62. 
c circular similarity of corresponding ring torsions (1.00 = identical; for methodological details see SI). 
d RMSDCA-ring = 0.714 Å. 
e RMSDCA-ring = 0.218 Å (AVPopen is a peptide-bond rotamer of UIIlasso which has the same backbone shape but a 
different peptide bond orientation at residues 2,3). Abbreviations: UII human urotensin-II, URP urotensin-related 
peptide, AVP Arg8-vasopressin (representative T16 states62), cl.open = clinched open, ap = antiparallel, p = parallel, 
dist = distorted, pbr = peptide bond rotamer, inv = inverse. 
 
 
Are Tail and Ring Conformation of Urotensin-II Mutually Dependent? 
As described above, the structure of UII can be characterized by its ring conformation and by 
treating the N-terminus as an additional residue. A principal-component analysis (PCA) of the 
overall-torsion space supports this approach. It clusters the overall conformations of UII in 
accordance to the ring-state types clustered with DASH40 (Figure 1). Nevertheless, the tail 
remains of special interest as it is the only structural difference between UII and URP. DASH 
clustering (Figures S1 to S6 of the SI) reveals that the basic conformation of the N-terminal tail 
is extended or folded with the majority of folded tail-conformations caused by a single turn 
centered at either P3D4 or D4C5 of turn-types β-I/VIII or II, as shown in Figure 2. 
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Figure 1. PCA clusters of UII conformations (3D-scatter plot of the three main PCs of the 
overall backbone torsion space of UII). Each dot represents a conformational snapshot of UII 
from the MD simulations. Conformations are color-coded by DASH ring-state types. PCA 
confirms that DASH clustering of ring conformations is suitable for characterizing the overall 
structure of UII. 
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Figure 2. Tail state types of urotensin-II. Hydrogen and oxygen atoms of hydrogen bonds are 
represented as spheres. 
 
The relative populations of extended and folded tail-states in the MD simulations vary 
significantly (cf. Figures S1 to S6 of the SI). Some ring-state types show frequent 
interconversions of extended and folded tail states, others none or few; and the extended:folded 
ratio for some types is not consistent between simulations. This raises the question as to whether 
tail and ring states might be mutually dependent. A qualitative answer is given by analyzing the 
weights of ring and tail torsions of the main significant PCs for each type of ring conformation 
(Table S4). If both ring and tail torsions are significantly loaded on one PC, correlation can be 
assumed. The results are summarized in Table 5. Few ring state types (folded-I and folded-IVb2) 
show unambiguously that ring and tail torsions are not correlated, whilst omega-I types show 
uncorrelated ring/tail motions only if the tail is exclusively extended (Figure S1). For all other 
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types, the PCA results suggest interdependence of ring and tail conformations. This contrasts 
with AVP, where the tail (the three C-terminal residues) moves essentially independently of the 
ring.62 A tentative explanation is the longer tail in UII of four residues facilitates interactions 
with the ring (e.g. by hydrogen bonding). Mutual dependence of ring and tail conformations is a 
dynamic property that differentiates UII from URP (no tail) and could modulate different 
bioactivities.  
 
Table 5. Relative Populations (%),a Interconversion Frequenciesb and Correlationc of Extended 
and Folded Tail-Conformation for UII Ring-State Types 
Ring-state type Correlation  Tail conformation
d 
Interconversion
 
MD
e 
 ring/tail  extended (%) folded (%) extended/folded  
omega-Ihbond/open no  100.0 (A)
 - - I 
 yes  38.1 (A) 61.9 (B) few III 
 yes  37.7 (A) 62.3 (C) frequent IV 
omega-II yes  100.0 (A) - - III 
 yes  61.9 (A) 38.1 (C) frequent XI 
scoop yes  100.0 (A) - - III 
lasso yes  40.8 (A) 59.2 (C) frequent IV 
circle yes  100.0 (A) - - IV 
folded-I no  88.6 (A) 11.4 (B) few II 
folded-IVb2 no  90.2(A) 9.80 (B) few III 
inv-folded yes  10.7 (A) 89.3 (C) few XI 
folded-II yes  - 100.0 (C) - V 
folded-III yes   100.0 (D,E,C)f - V 
a Populations are relative to the length of analyzed sections occupied by single ring-state types in the MD 
simulations listed. MD = MD simulation (DASH ring and tail-state trajectories are given in Figure S1 to S6 of the 
SI). 
b cf. DASH tail-state trajectories. 
c Qualitative results from the overall torsion space PCA: If relevant PCs (Eigenvalue > 1.0) correspond to both 
ring and tail torsions, then correlation was assumed (for details, see SI). 
d Turn types (Figure 2) are in parentheses. 
e MD = MD simulation (DASH ring and tail-state trajectories are given in Figure S1 to S6 of the SI). 
f 40.9%(D) + 32.9%(E) + 26.2%(C). 
 
 
Conformations of Urotensin Related Peptide. 
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In total, 22.8 µs MD were analyzed for URP (Table S1 of the SI). In the MD simulations, the 
majority of URP conformations (98.4%) belong to the open class of omega ring-state types 
(Table 6, Table S3) with the turn centered at residues K5 and Y6 and a circular similarity of more 
than 90% to the omega states of UII (Table 4). A high similarity of UII and URP ring-
conformation was postulated also by Brancaccio et al. based on their NMR studies.31 Hydrogen-
bond populations at Y4O-C7HN and turn propensities at K5Y6 of URP´s omega type resemble the 
data of the corresponding UII conformations (Tables 2 and 3). Conformations with turns 
different to K5Y6 are only found as transient states with low absolute populations. There is a 
variant of the UII lasso type with a type VIII β-turn centered at F3W4. Two further transient 
states are comparable with the folded conformations of UII. One (denoted as sheet) forms an 
anti-parallel β-sheet with a β-II turn at W4K5, the other (denoted as hybrid) exhibits a γ-turn at 
W4K5Y6 and shows 89% similarity to the ring torsions of the folded-IVb2 state of UII. The sheet 
type resembles the postulated single-conformer structure of URP in SDS micelle solution.31 The 
hybrid type reminiscent of Chatenet´s NMR-based single-conformer description of URP in 
aqueous solution.15  
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Table 6. Classification of Ring Conformations of URPa  
Open 
Ring-state type Turn type H-bond Subtype Cartoon IDb 
Turn centered at KY (5,6) 
 
5,6 β-I 4O-7H omega-Ihbond 
 
1r 
5,6 β-VIII open omega-Iopen 3r 
5,6 β-II open omega-II 2r 
Turns centered at FW (3,4) 
 
3,4 β-VIII open lasso45pbr 
 
6r 
Folded (saddle-like) 
Ring-state type Turn type H-bond Subtype Cartoon IDb 
Turn centered at K (5) 
 
4,5,6 γ 4O-6H hybrid 
 
4r 
turn centered at WK (4,5) 
 
2-7 antip. 
β-sheet 
(4,5 β-II) 
6O-3H 
(3O-6H)c 
sheet 
 
5r 
a Ring-state types are characterized by their turn centers (blue) and the donor oxygen for transannular hydrogen-
bond interactions (red). Sidechains are indicated by the single-letter code of the residue. Turn types and 
corresponding hydrogen bonds populated > 70% are listed. 
b Mean torsion angles (Table S3) and coordinate files of representatives are given in the SI (ID = ID of 
representative). 
c 48% population.  
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Determination of UII and URP Equilibrium Populations. 
Most of the ring-state types described above exhibit significant lifetimes during MD 
simulation and, therefore, represent candidates for the main conformations in solution. However, 
interconversions are too infrequent to derive equilibrium populations directly from the MD 
simulations. We therefore performed extended REMD simulations of UII and URP to determine 
the relative population of the states and, hence, to calculate their free energies. NMR 
experiments were carried out to validate these in silico equilibria via comparison of calculated 
and experimental chemical shifts using the statistical metrics reported previously.61 
 
 
NMR Experiments. 
1H, 13C, and 15N chemical shifts could be assigned for UII and URP in H2O at pH 3.0/3.5 and 
6.0, with the exception of C and N atoms without directly bonded protons and some rapidly 
exchangeable HN atoms at pH 6.0. Our 1H chemical shifts of UII and URP agree well with those 
already published15, 28, 30, 31 and are complemented by our results for 13C and 15N shifts at the 
different pH values. The experimental shift lists are given in the SI (Tables S5-S8). The pH was 
varied to see if changing the protonation state induces significant conformational changes. A 
change to acidic pH values protonates charged carboxylic acid-containing residues (E1, D3, and 
the C-terminal V11 in UII; the C-terminal V8 in URP) and this can affect the local electronic 
structure, as seen by changes in NMR chemical shifts of these residues and their immediate 
neighbors. The UII peptide is more affected by pH, changing its protonation state from -1 at pH 
6.0 to +2 at pH 3.0, whereas URP only changes from +1 at pH 6.0 to +2 at pH 3.0. However, 
these pH-dependent changes are small compared to those that occur if the solvent is changed 
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from water to an SDS micelle containing aqueous solution, with no buffer added.28, 31 A 
significant conformational change such as that found in SDS micelles28, 31 can be excluded. Thus, 
it can be assumed that the most highly populated conformations of UII and URP at pH 6.0 
resemble the published NMR structures in aqueous solution. We eschewed a further classical 
structure determination using experimental nuclear Overhauser effect (NOE)-distances or 
coupling constants and focused on determining conformational equilibrium concentrations via 1H 
chemical shifts, which proved to be most efficient for vasopressin.61 In this context, it is 
important to note that, while observed NMR chemical shifts represent the time-average of the 
shifts of all structures in a dynamic equilibrium, this is not true of distances derived from NOE 
peaks. This is because the distance-dependence of the NOE depends on the inverse sixth power 
(r−6),64 so that simply averaging the distance (r) will yield incorrect results. Thus, short contacts 
that occur infrequently can give rise to significant NOE peaks, even though the time-averaged 
inter-atom distance may be large. For the same reason, NOE peaks that result from several 
different conformations in equilibrium can masquerade as a single fictitious conformation. A 
second set of resonances representing a minor population (~10% of the total) was also observed 
in the UII NMR spectra. This was identified as the cis-Pro3 isomer of UII and fully sequentially 
assigned. As the cis/trans conversion in peptides is known to be slow on the NMR timescale65, 66 
it will not contribute to fast equilibria and is not discussed here. 
 
 
Conformational Equilibrium of Urotensin-II. 
The relative populations for the representative conformations of UII from three REMD 
simulations (with different initial conformations) are given in Table 7. This table covers 
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approximately 80% of the conformational REMD snapshots, the remaining 20% (circular 
similarity of ring torsions < 65%) are transients that cannot be assigned unambiguously to the 
representatives. All three REMD simulations predict a similar ratio of open to folded 
conformations and, thus, the simulations can be assumed converged for these main 
conformational types. Unfortunately, the population of the individual sub-types of open and 
folded has not converged and differs strongly between the three REMD simulations (Table 7). 
However, convergence would necessitate significantly longer simulation times which are 
currently unobtainable. 
 
Table 7. Relative Free Energies (∆∆G, kcal mol-1)a and Relative Populations (%)b of 
Representative Conformations for UII from REMD Simulations 
UII representatives REMD simulations (UII)
 
 
REMD-I
c 
REMD-II
 
REMD-III
 
stddev
d 
Conformation ID
e 
∆∆G pop% ∆∆G pop% ∆∆G pop% ∆∆G pop% 
omega-Iopen 1 0.39 15.19 1.08 8.72 1.09 8.98 ±0.33 ±2.99 
omega-Ihbond 2 0.41 14.76 1.45 4.68 1.19 7.69 ±0.44 ±4.22 
omega-II 3 1.04 5.07 2.21 1.29 1.55 4.10 ±0.48 ±1.61 
lasso 4 0.00 29.75 0.00 54.11 0.00 56.73 ±0.00 ±12.15 
scoop 5 1.43 2.67 3.08 0.30 3.37 0.20 ±0.85 ±1.14 
circle 10 1.12 4.53 2.16 1.39 2.08 1.68 ±0.47 ±1.42 
Σ open   72.0  70.5  79.4   
folded-I 6 1.67 1.76 1.71 3.00 2.00 1.82 ±0.15 ±0.57 
folded-IVb2 7 2.28 0.63 3.01 0.34 3.13 0.28 ±0.38 ±0.15 
inv.folded 11 0.35 16.39 1.02 9.67 0.75 15.96 ±0.28 ±3.07 
folded-II 8 1.21 3.89 1.34 5.58 1.84 2.56 ±0.27 ±1.24 
folded-III 9 1.02 5.37 0.95 10.92 - 0.00 ±0.04 ±4.46 
 Σ folded   28.0  29.5  20.6   
a Average standard deviation of all ∆∆G is 0.37 kcal mol-1. 
b Total population of assigned representatives: REMD-I 82%, II 77%, III 87%. 
c The REMD-I equilibrium gives the best agreement with experiment. 
d stddev = standard deviation. 
e Coordinate files are available as SI. ID = ID of representative. 
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A statistical comparison of the calculated and experimental chemical shifts of UII at pH 6 is 
given in Table 8. All open:folded equilibria of UII correspond better to the experimental values 
than any single conformation. The best agreement was found for equilibrium REMD-I, 
predicting a ratio of 72% open and 28% folded conformations for UII in aqueous solution. A plot 
of the predicted vs experimental shifts is shown in Figure 3. Correlation of calculated and 
experimental 15N chemical shifts also confirms the ratio of 72:28 open to folded as the 
equilibrium that gives the best agreement, although the number of shifts is very small (Table S14 
of the SI). The correlation of calculated 
13C chemical shifts with experimental shifts is 
satisfactory for the equilibria but gives the best fit for the omega-Iopen conformations (Table S13 
of the SI). However, the correlation within the calculated sets of 13C shifts is too high to give 
unambiguously distinguishable models (Figure S8). This was also found for AVP61 and is further 
discussed in the SI.  
Smith and Goodman have proposed the so-called DP4-metric, which they designed specially to 
discriminate between conformations on the basis of the agreement between calculated and 
experimental NMR chemical shifts.67 The DP4 probability is based on Bayes’ theorem and is 
intended to provide an objective assessment of how likely it is that a given diastereomer (or in 
our case equilibrium distribution of conformations) is correct based on calculated and 
experimental chemical shifts. In our case the DP4 probabilities for both 13C and 1H shifts help 
confirm that the chemical shift ensemble resulting from equilibrium REMD-I (72:28) has the 
highest probability of being a correct assignment (Tables S15 of the SI) in comparison to the 
single conformations or the equilibria REMD-II and –III. Finally, the dependence of DP4 (“best-
fit probability”) on variations of the open:folded ratio also results in a clear maximum for an 
equilibrium at approximately 70:30 (Figure 4), in accordance with our prediction. 
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Table 8. Statistical Error Values (ppm), Coefficients of Distinctiveness (∆σ) and Determination 
(R2) for the Linear Regression of Calculated and Experimental 1H Chemical Shifts of UII in 
Aqueous Solution at pH 6.0 
UII representatives and equilibria (open:folded) MSE MUE RMSD WRMSE ∆σ R
2 
omega-Iopen -0.09 0.38 0.51 0.56 1.11 0.934 
omega-Ihbond -0.02 0.31 0.42 0.46 0.99 0.956 
omega-II 0.03 0.33 0.43 0.46 1.02 0.953 
lasso 0.03 0.29 0.35 0.38 0.96 0.968 
scoop 0.03 0.41 0.50 0.54 1.26 0.938 
circle 0.00 0.30 0.40 0.42 0.95 0.962 
folded-I 0.04 0.32 0.39 0.43 1.06 0.963 
folded-IVb2 0.11 0.32 0.39 0.40 1.01 0.966 
inv-folded 0.06 0.34 0.42 0.44 1.14 0.955 
folded-II 0.05 0.40 0.49 0.55 1.15 0.936 
folded-III -0.04 0.37 0.45 0.50 1.19 0.946 
Equilibrium REMD-I (72:28) 0.01 0.21 0.26 0.27 0.75 0.982 
Equilibrium REMD-II (70:30) 0.01 0.22 0.28 0.29 0.78 0.980 
Equilibrium REMD-III (79:21) 0.02 0.23 0.29 0.30 0.81 0.979 
The best results are shown in bold. MSE = Mean Square Error; MUE = Mean Unsigned Error; RMSD = Root 
Mean Square Deviation; WRMSE = Weighted Root MSE; ∆σ = coefficient of distinctiveness;
61 R2 = coefficient of 
determination 
 
 
Figure 3. Linear regression of calculated 1H chemical shifts for the best predicted equilibria of 
open and folded conformations of UII and URP against experimental chemical shifts of non-
exchangeable 1H of UII and URP in aqueous solution at pH 6.0, 298K. 
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Figure 4. Dependence of DP4 probabilities on the open:folded ratio of UII. Open and folded 
subtype mixtures correspond to the relative concentrations of the 11-component 
equilibrium REMD-I. The maximum probability (most likely ratio) is approximately 70:30 
open:folded. 
 
Besides the experimental shifts of UII at pH 6, a second set of experimental shifts at pH 3 was 
measured and compared with the calculated shifts. The statistical metrics (data not shown) are 
extremely close to those at pH 6 which suggests conformational independence of UII for 
different protonation states (+2 at pH 3, -1 at pH 6).  
 
The seemingly contradictory experimental single-conformer interpretations of UII´s structure 
in H2O (no classical turns
28 vs widened 7,8,9+8,9,10 γ-turns30) are more precisely a fast (on the 
NMR timescale) equilibrium of major open and minor folded ring-conformations, rather than any 
single conformation. A folded conformation has so far only been proposed from NMR 
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experiments in SDS micelles, and was suggested to be the bioactive conformation in the UII 
receptor (UTR).28 Our results indicate that the proposed bioactive folded-type conformations 
already exist in aqueous solution to a significant extent, hidden in the fast equilibrium and that, if 
it is the bioactive conformation, it is selected by preferential binding to the receptor from the 
conformational ensemble. 
 
 
Conformational Equilibrium of Urotensin Related Peptide. 
Three REMD simulations of URP starting from different initial conformations gave the 
relative free energies and populations listed in Table 9. The representatives cover approximately 
70% of all REMD conformations. The remaining 30% (circular similarity of ring torsions < 
65%) are transient conformations that could not be assigned unambiguously. The overall ratio of 
open:folded conformations from different REMD simulations are again similar and can be 
regarded as converged. 
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Table 9. Relative Free Energies (∆∆G, kcal mol-1)a and Relative Populations (%)b of 
Representative Conformations for URP from three different REMD Simulationsa,b,c 
URP representatives REMD simulations (URP)
 
 
REMD-IV
c 
REMD-V REMD-VI stddev
d 
Conformation ID
e 
∆∆G % ∆∆G % ∆∆G % ∆∆G % 
omega-Iopen 3r 0.34 18.92 1.38 5.80 0.45 19.70 ±0.47 ±6.38 
omega-Ihbond 1r 0.08 29.73 0.49 26.09 0.33 24.24 ±0.17 ±2.28 
omega-II 2r 0.00 33.78 0.00 59.42 0.00 42.42 ±0.00 ±10.65 
lasso 6r 1.26 4.05 1.79 2.90 1.32 4.55 ±0.24 ±0.69 
Σ open   86.5   94.2   90.9   
sheet 5r 0.71 10.14 1.38 5.80 1.73 2.27 ±0.42 ±3.22 
hybrid 4r 1.36 3.38 - 0.00 1.08 6.82 ±0.14 ±2.78 
 Σ folded   13.5   5.8   9.1   
a Average standard deviation 0.29 kcal mol-1. 
b Total population of assigned representatives: REMD-IV 74%, V 69%, VI 66%. 
c The REMD-IV equilibrium gives the best agreement with experiment. 
d stddev = standard deviation. 
e Coordinate files are available as SI. ID = ID of representative. 
 
Table 10. Statistical Error Values (ppm), Coefficients of Distinctiveness (∆σ) and Determination 
(R2) for the Linear Regression of Calculated and Experimental 1H Chemical Shifts of URP in 
Aqueous Solution at pH 6.0 
URP representatives and equilibria (open:folded) MSE MUE RMSD WRMSE ∆σ R
2 
omega-Iopen -0.02 0.27 0.37 0.43 1.02 0.9774 
omega-Ihbond -0.09 0.32 0.44 0.55 0.99 0.9624 
omega-II -0.11 0.40 0.53 0.64 1.20 0.9456 
lasso -0.08 0.41 0.52 0.64 1.26 0.9489 
sheet -0.05 0.28 0.38 0.43 1.01 0.9755 
hybrid -0.01 0.33 0.44 0.53 1.12 0.9666 
Equilibrium REMD-IV (86:14) -0.08 0.22 0.29 0.31 0.78 0.9847 
Equilibrium REMD-V (94:6) -0.10 0.29 0.38 0.44 0.91 0.9723 
Equilibrium REMD-VI (91:9) -0.08 0.25 0.31 0.35 0.84 0.9815 
The best results are shown in bold. MSE = Mean Square Error; MUE = Mean Unsigned Error; RMSD = Root 
Mean Square Deviation; WRMSE = Weighted Root MSE; ∆σ = coefficient of distinctiveness; R
2 = coefficient of 
determination 
 
The model that agrees best with experiment is the equilibrium from REMD-IV (calculated 1H 
chemical shifts for URP are given in Table S12 of the SI) predicting a ratio of 86% open and 
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14% folded conformations for URP with a predominance of omega conformations (Table 10, 
Figure 3). This result is further supported by the DP4 assignment probabilities (Tables S15). 
Equilibrium REMD-VI also performs better than any single conformation. Only equilibrium 
REMD-V fits worse than the omega-Iopen conformation. It is noteworthy that the average ratio of 
the frequently interconverting conformations omega-Iopen and omega-Ihbond in the long-scale MD 
simulations is 42:58. This resembles the relative populations of REMD-IV (39:61) and VI 
(45:55), but not REMD-V (18:82). Insufficient convergence of the omega-Iopen:omega-Ihbond ratio 
may explain the poor performance of equilibrium REMD-V.  
 
How do the conformational equilibria of URP and UII differ? Both exhibit predominantly open 
conformations in aqueous solution but UII shows a higher population of folded conformations 
(UII: 28%, URP: 14%). This result is consistent with the possible interdependence of ring and 
tail conformation in UII but not URP, and supports the hypothesis that the N-terminal tail 
facilitates the formation of folded ring conformations. 
 
CONCLUSIONS 
Conformation and dynamics of UII and URP in aqueous solution were explored and classified 
by combining computational and experimental methods. The two peptides exhibit similar ring 
conformations. The structures of both UII and URP in aqueous solution cannot be described by 
single conformations. As found previously for Arg8-vasopressin,61 UII and URP exist in solution 
in a conformational equilibrium between open and folded (saddle-like) ring conformations and in 
combination with extended and folded tail conformations. In contrast to vasopressin, however, 
the ring and tail conformations of UII are not independent of each other, so that UII behaves 
differently to URP, as URP lacks the tail region. Folded (saddle-like) conformations of URP 
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appear only transiently in unrestricted MD simulations and the equilibrium distribution of 
conformations that results from REMD simulations and agrees best with experimental 1H 
chemical shifts is 86% open : 14% folded. The corresponding equilibrium for UII is 
72% open : 28% folded. These data suggest that the free-energy penalty for a possible folded 
biologically active conformation is approximately 1.1 kcal mol-1 for URP but considerably 
smaller (approximately 0.6 kcal mol-1) for UII, probably because of ring-tail interactions in UII. 
This difference may be significant in determining different effects of the two peptides on binding 
to the UII-receptor (UT2SR, UTR). The high similarity of ring-conformations of UII and URP 
support Brancaccio´s finding31 that differences in the biological function are not related to 
differences in ring-conformations. UII and URP show the same conformational main-types as the 
structurally related GPCR-ligand Arg8-vasopressin. However, both prefer open-type 
conformations in solution, in strong contrast to AVP (70% folded conformations). 
All thermodynamically accessible representative conformations of UII and URP can serve as 
templates for 3D ligand-based drug design or docking, the structural data are given in the SI. 
The NMR data reported here supplement and complete published data. They include an almost 
complete assignment of the spectra of the cis-Pro3 isomers of UII. We have developed a novel 
and robust procedure to extract conformational equilibria from NMR data by combining 
experiment with enhanced sampling simulations. The protocol was developed on AVP61 and 
tested here on UII and URP. It seems a powerful tool for exploring the conformational equilibria 
of intrinsically flexible peptides. In the case of UII and URP, we have used REMD to determine 
the calculated equilibrium concentrations, rather than the metadynamics procedure used for 
AVP. Future work will evaluate a variety of enhanced-sampling protocols in order to determine 
the most suitable for peptide conformational equilibria. 
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The protocol tested and published61 for Arg8-vasopressin and based on proton chemical shifts 
also yields well-defined predictions for UII and URP, here using REMD to determine the 
calculated equilibrium concentrations. 
Unfortunately, we have little information about the lifetimes of the individual conformations. 
The conformational equilibria are fast on the NMR time scale but too slow for us to be able to 
sample them adequately in unbiased simulations.   
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